Leah Kuntz

Finding a program that is a good fit while LGBTQ+ may be more difficult than it seems…

Young, professional women in academic psychiatry are facing down the iceberg: gender discrimination.

According to Nora D. Volkow, MD, Director of the National Institute on Drug Abuse, drug use and overdose deaths have significantly increased since the outset of the pandemic. What made it worse?

Data presented at the 2021 APA Virtual Annual Meeting show promise for treating schizophrenia.

Can depression be passed on to future generations, and if it can, how can treatment help?

One doctor at the APA Virtual meeting explains how ketamine can rebuild spine and synaptic proteins in the brain, but may be difficult to actually prescribe to patients.

The FDA approved a higher dose of naloxone to treat opioid overdose deaths.

The Drug Enforcement Administration has freed this formerly schedule II controlled substance.

Looking to reduce youth initiation into tobacco products, the FDA takes steps against menthol cigarettes and flavored cigars.

The FDA cleared the way to use this deep transcranial magnetic stimulation system, which may be able to help treat depression in less than 5 minutes.

A recent study evaluated the everyday efficacy of this novel treatment for major depressive disorder.

A new risperidone capsule for the treatment of schizophrenia sees positive phase 2 study results.

These states will receive funding to increase competitive integrated employment for patients with mental health conditions.

Patients with depression may have altered cortical processing of visual contrast during a major depressive episode.

While this digital therapy failed to meet its primary endpoint in a recent clinical trial, results suggest it may improve paranoia in general.

This year, the March of the Living honors of Holocaust victims and survivors, the medical community, and Dr Anthony Fauci.

CRL cites lack of substantial evidence of efficacy needed for approval.

This once-daily sprinkleable capsule may help patients aged 6 to 17 years with attention-deficit/hyperactivity disorder.

Is this treatment for bipolar disorder risking patients’ heart health?

Government funding for the drug addiction crisis is on the way.

The first study to gather unsolicited patient responses via social media finds 3 negative themes.

Service animals can help save veterans’ lives.

This investigational dual orexin receptor antagonist improved sleep overnight and daytime functioning.

As patients flock to CBD as a “natural alternative” to medications, the FDA continues to crack down on false claims.

An ex-Yale psychiatrist who skirted the Goldwater Rule is suing the university over her termination.

Misdiagnosis and late diagnosis may be preventing older patients with bipolar disorder from getting proper care.

This monoclonal antibody showed significant slowing of decline in patients with Alzheimer disease.

This social anxiety disorder treatment does not directly activate gamma-amino butyric acid (GABA-A) receptors, setting it apart from benzodiazepines.

It’s time for psychiatry to take the high road in addressing racism, especially as the psychological toll becomes more evident.

New data from the ongoing SHORELINE study may bring good news for treating MDD.